Functional Fluidics (https://www.functionalfluidics.com/) recently participated in a pivotal study that indicates their biomarkers of red blood cell health can help define and predict acute pain crises in individuals with Sickle Cell Disease (SCD). This addresses a tremendous need for well-validated biomarkers to objectively monitor red blood cell health in individuals with sickle cell disease.
It's official - Materna Medical has been named a Fast Company World Changing Ideas finalist. Along with Alydia Health, Medtronic, and Merck, we "represent the kind of innovative thinking that will hel
KANSAS CITY, Mo., April 27, 2021 (GLOBE NEWSWIRE) -- Today, TripleBlind announced that it expanded its collaboration with Mayo Clinic, which invested in a seed extension round, the only investor parti
By: Jonathan B. Jaffery & Dana Gelb Safran As payers are increasingly holding providers financially accountable for outcomes under value-based payment arrangements, there is growing concern that organ